Vanda Pharmaceuticals buy StockNews.com
Start price
30.03.24
/
50%
€3.92
Target price
30.03.25
-
Performance (%)
44.13%
Price
25.07.24
€5.65
Summary
This prediction is currently active. With a performance of 44.13% the BUY prediction by StockNews_com is a big success. This prediction currently runs until 30.03.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vanda Pharmaceuticals | 0.893% | 0.893% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat